Clinical Epigenetics

Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms, as well as reports on defects of epigenetic regulation, in relation to human disease, diagnosis and therapy. Epigenetic research in disease model organisms is particularly welcome.

Editor-in-Chief

Ulrich Mahlknecht, St Lukas Clinic, Solingen

Editorial Board | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Case study

DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population

Kullmann K, Deryal M, Ong MF, Schmidt W and Mahlknecht U Clinical Epigenetics 2013, 5:7 (2 May 2013)
Research

Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia

Sundrani DP, Reddy US, Joshi AA, Mehendale SS, Chavan-Gautam PM, Hardikar AA, Chandak GR and Joshi SR Clinical Epigenetics 2013, 5:6 (26 April 2013)
Reviewer Acknowledgement

Reviewer acknowledgement 2013

Mahlknecht U Clinical Epigenetics 2013, 5:4 (2 April 2013)
Research

Variation in ultraviolet radiation and diabetes: evidence of an epigenetic effect that modulates diabetics’ lifespan

Davis GE and Lowell WE Clinical Epigenetics 2013, 5:5 (2 April 2013)
Review

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

Karahoca M and Momparler RL Clinical Epigenetics 2013, 5:3 (1 February 2013)
Research

BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer

van Roon EH, Boot A, Dihal AA, Ernst RF, van Wezel T, Morreau H and Boer JM Clinical Epigenetics 2013, 5:2 (16 January 2013)
Research

The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years

Soto-Ramírez N, Arshad SH, Holloway JW, Zhang H, Schauberger E, Ewart S, Patil V and Karmaus W Clinical Epigenetics 2013, 5:1 (3 January 2013)
View more articles

RSS

Epigenetics news

20 May 2013: Mechanism linking key inflammatory marker to cancer identified

09 May 2013: Epigenomics of stem cells that mimic early human development charted

09 May 2013: Mapping the embryonic epigenome: How genes are turned on and off during early human development

Society information

The "Clinical Epigenetics Society" (CLEPSO) is a non-profit organization founded at Saarland University.

The society has five main objectives:

Promotion and support of scientific research projects and initiatives within the field of clinical epigenetics.
Promotion of the scientific exchange amongst its members.
Encouragement and support of relations to national and international societies within the area of clinical and translational research.
Development of an international research and scientific network within the field of clinical epigenetics.
Providing a forum for encouraging discussions and contributions to the advancement of clinical epigenetics, through the Clinical Epigenetics journal, Blogs, scientific symposia, meetings, and newsletters.

Editor's profile

Ulrich Mahlknecht

Ulrich Mahlknecht is currently a Professor of medicine at the University of Heidelberg, and Head of the Department of Hematology/Oncology at St. Lukas Clinic in Solingen, Germany.

His research focuses on novel targeted immunological and epigenetic concepts in the treatment of solid tumors and hematological malignancies.

Archival content

In October 2011, Clinical Epigenetics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. To view the journal's content prior to this transition, please see SpringerLink.

Flavour on Twitter